These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34382808)

  • 1. Discovery of an Orally Bioavailable Small-Molecule Inhibitor for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Wang Z; Zhang M; Quereda V; Frydman SM; Ming Q; Luca VC; Duckett DR; Ji H
    J Med Chem; 2021 Aug; 64(16):12109-12131. PubMed ID: 34382808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Li Z; Zhang M; Teuscher KB; Ji H
    J Med Chem; 2021 Aug; 64(15):11195-11218. PubMed ID: 34270257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Wang Z; Zhang M; Luo W; Zhang Y; Ji H
    J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in β-catenin/BCL9 protein-protein interaction inhibitors.
    Zhang H; Bao Y; Liu C; Li J; Zhu D; Zhang Q
    Future Med Chem; 2021 May; 13(10):927-940. PubMed ID: 33849283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
    Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
    Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
    Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
    Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Novel 1-Phenylpiperidine Urea-Containing Derivatives Inhibiting β-Catenin/BCL9 Interaction and Exerting Antitumor Efficacy through the Activation of Antigen Presentation of cDC1 Cells.
    Zhu W; Liu C; Xi K; Li A; Shen LA; Li Y; Jia M; He Y; Chen G; Liu C; Chen Y; Chen K; Sun F; Zhang D; Duan C; Wang H; Wang D; Zhao Y; Meng X; Zhu D
    J Med Chem; 2024 Aug; 67(15):12485-12520. PubMed ID: 38912577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
    Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
    Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Zhang M; Wang Z; Zhang Y; Guo W; Ji H
    J Med Chem; 2018 Apr; 61(7):2989-3007. PubMed ID: 29566337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors.
    Sang P; Zhang M; Shi Y; Li C; Abdulkadir S; Li Q; Ji H; Cai J
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10757-10762. PubMed ID: 31088961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety.
    Catrow JL; Zhang Y; Zhang M; Ji H
    J Med Chem; 2015 Jun; 58(11):4678-92. PubMed ID: 25985283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
    Yan M; Li G; An J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of selective small-molecule inhibitors for β-catenin/B-cell lymphoma 9 protein-protein interactions.
    Hoggard LR; Zhang Y; Zhang M; Panic V; Wisniewski JA; Ji H
    J Am Chem Soc; 2015 Sep; 137(38):12249-60. PubMed ID: 26352795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric inhibitor of β-catenin selectively targets oncogenic Wnt signaling in colon cancer.
    Cheltsov A; Nomura N; Yenugonda VM; Roper J; Mukthavaram R; Jiang P; Her NG; Babic I; Kesari S; Nurmemmedov E
    Sci Rep; 2020 May; 10(1):8096. PubMed ID: 32415084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ZW4864 Derivatives as Small-Molecule Inhibitors for the β-Catenin/BCL9 Protein-Protein Interaction.
    Wang Z; Zhang M; Thompson HM; Ji H
    ACS Med Chem Lett; 2022 May; 13(5):865-870. PubMed ID: 35586435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a Novel Small-Molecule Inhibitor that Targets PP2A-β-Catenin Signaling and Restricts Tumor Growth and Metastasis.
    Maheshwari S; Avula SR; Singh A; Singh LR; Palnati GR; Arya RK; Cheruvu SH; Shahi S; Sharma T; Meena S; Singh AK; Kant R; Riyazuddin M; Bora HK; Siddiqi MI; Gayen JR; Sashidhara KV; Datta D
    Mol Cancer Ther; 2017 Sep; 16(9):1791-1805. PubMed ID: 28500231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
    Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives.
    Wang Z; Li Z; Ji H
    Med Res Rev; 2021 Jul; 41(4):2109-2129. PubMed ID: 33475177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.